-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Initiates Coverage On Sensei Biotherapeutics with Buy Rating, Announces Price Target of $55

Benzinga·06/11/2026 10:15:57
Listen to the news
BTIG analyst Jeet Mukherjee initiates coverage on Sensei Biotherapeutics (NASDAQ:SNSE) with a Buy rating and announces Price Target of $55.